These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1544716)

  • 1. c-myc over-expression in human primary ovarian tumours: its relevance to tumour progression.
    Tashiro H; Miyazaki K; Okamura H; Iwai A; Fukumoto M
    Int J Cancer; 1992 Mar; 50(5):828-33. PubMed ID: 1544716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
    Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
    APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours.
    Dimova I; Raitcheva S; Dimitrov R; Doganov N; Toncheva D
    Eur J Cancer; 2006 Mar; 42(5):674-9. PubMed ID: 16458500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
    Berns EM; Klijn JG; Henzen-Logmans SC; Rodenburg CJ; van der Burg ME; Foekens JA
    Int J Cancer; 1992 Sep; 52(2):218-24. PubMed ID: 1325950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression.
    Mandai M; Konishi I; Komatsu T; Mori T; Arao S; Nomura H; Kanda Y; Hiai H; Fukumoto M
    Br J Cancer; 1995 Sep; 72(3):691-5. PubMed ID: 7669582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer.
    Skírnisdóttir IA; Sorbe B; Lindborg K; Seidal T
    Int J Gynecol Cancer; 2011 Feb; 21(2):236-44. PubMed ID: 21270607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.
    Browne A; Sriraksa R; Guney T; Rama N; Van Noorden S; Curry E; Gabra H; Stronach E; El-Bahrawy M
    Cytokine; 2013 Oct; 64(1):413-21. PubMed ID: 23727325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The amplification of c-myc, N-ras, c-erb B oncogenes in ovarian malignancies].
    Xin XY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jul; 28(7):405-7, 442. PubMed ID: 8287725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
    Saied EM; El-Etreby NM
    Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a homeobox gene (SIX5) in borderline ovarian tumours.
    Winchester C; Robertson S; MacLeod T; Johnson K; Thomas M
    J Clin Pathol; 2000 Mar; 53(3):212-7. PubMed ID: 10823141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of c-ras-Ki oncogene in human ovarian tumours.
    Boltz EM; Kefford RF; Leary JA; Houghton CR; Friedlander ML
    Int J Cancer; 1989 Mar; 43(3):428-30. PubMed ID: 2925274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.
    Wisman GB; Hollema H; Helder MN; Knol AJ; Van der Meer GT; Krans M; De Jong S; De Vries EG; Van der Zee AG
    Int J Oncol; 2003 Nov; 23(5):1451-9. PubMed ID: 14532990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
    Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of amplifications of myc gene (c-myc and N-myc) in human ovarian cancer].
    Kataoka A; Yakushiji M; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma.
    Shin K; Kim KH; Yoon MS; Suh DS; Lee JY; Kim A; Eo W
    Adv Clin Exp Med; 2016; 25(3):513-21. PubMed ID: 27629740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer.
    Chen CH; Shen J; Lee WJ; Chow SN
    Int J Gynecol Cancer; 2005; 15(5):878-83. PubMed ID: 16174239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.